Custom Peptide Synthesis Services
Abcepta is a leading provider of high-quality peptide synthesis services. Based on decades of experience, Abcepta peptide chemists craft optimized coupling reactions, carefully select building blocks and resins, deploy case-specific methods to circumvent hydrophobic interactions, and devise backup routes in the event of synthetic difficulties. We consult with you during project design, at critical project junctures, and post-delivery with free lifetime technical support. We take your custom peptide expectations personally, and we are relentless in delivering satisfaction on every aspect of your project.
Abcepta’s Advantages:
Specialists in both
routine & challenging peptides |
|
High yield quality products
at your specified purity level |
|
|
|
Custom Peptide Synthesis - A Comprehensive Service
Peptide Form |
Single peptides |
Peptide Scale |
From milligram to multi-gram scale |
Peptide Purification |
HPLC purification up to 98% (Crude peptide also available) |
Peptide Length |
Routine synthesis of peptides ≤ 30 aa. Long peptide synthesis using special chemistry (40-100 aa) |
Modifications |
Phosphorylation, methylation, acetylation, biotinylation, MAPS (4 or 8 chalns). Please inquire for other modification |
Labels |
FITC, rhodamine, TAMRA. Please inquire for other labels |
Conjugations |
Keyhole limpet hemocyanin (KLH), BSA, Hydralink |
Cyclization |
S-S |
Analysis |
Liquid chromatography, mass spectrometry (LC/MS) |
Libraries |
Customized. Please inquire |
Allquoting |
Order your peptides pre-allquoted for greater convenience. |
Satisfied Customer Testimony:
“Abcepta succeeded with a challenging custom peptide where a number of other suppliers failed. Abcepta’s remarkable success in this effort gave us confidence that we would be able to move forward with a program centered around this peptide. During candidate selection and manufacturing optimization, Abcepta always came back to us with far more than we had asked or expected. They remain a key part in our peptide program moving forward.”
Todd C. Zankel
Chief Science Officer
Raptor Pharmaceutical, Inc.